Colony-Stimulating Factor Receptors G-CSFR, M-CSFR, and GM-CSFR in Disease and Drug Discovery

View All Products About Colony-Stimulating Factor Receptors G-CSFR, M-CSFR, and GM-CSFR Granulocyte Colony-Stimulating Factor Receptor, Macrophage Colony-Stimulating Factor Receptor, and Read More...

IchorBio Citations

View All Products ichorbio Citations Please see below for a full list of ichorbio publications arranged in date order. ichorbio Read More...

Adrenergic Receptors In Disease and Drug Discovery

View All Products Adrenergic receptors, a class of G protein-coupled receptors (GPCRs), play a pivotal role in mediating the physiological Read More...

Alpha-1 Adrenergic Receptors in Disease and Drug Discovery

View All ProductsProducts Adrenergic receptors, a class of G protein-coupled receptors (GPCRs), play a pivotal role in mediating the physiological Read More...

Oxytocin Receptor in Disease and Drug Discovery

View All Products The Oxytocin Receptor (OXTR) What is the Oxytocin Receptor (OXTR)? The Oxytocin Receptor (OXTR) is a vital Read More...

Understanding Assay Performance Metrics

View All Products When embarking on the search for a reliable cell-based assay, it's common practice to start by typing Read More...

Hepatocyte Nuclear Factor 4 Alpha in Disease and Drug Discovery

View All Products The Hepatocyte Nuclear Factor 4 Alpha (HNF4α) What is the Hepatocyte Nuclear Factor 4 Alpha (HNF4α)? The Read More...

Base editing technology leads a new chapter in drug development

View All Products Since its debut in 2016, base editing technology has opened up new perspectives and methods for drug Read More...

MSLN Targeted Drugs Entering the Fast Lane

View All Products Since December 2023, there have been several positive updates about drugs targeting MSLN. On December 19th, RemeGen Read More...

Exploring the Most Commonly Used PD-1 Antibody Clones for In Vivo Research

View All Products Introduction Programmed cell death protein 1 (PD-1) has emerged as a crucial target for cancer immunotherapy, with Read More...

PROMISING BISPECIFICS IN CLINICAL TRIALS: AUG 2023

View All Products Bispecific antibodies have emerged as a promising class of therapeutic agents in the field of cancer immunotherapy. Read More...

TILVESTAMAB: A COMPREHENSIVE OVERVIEW

View All Products Tilvestamab Biosimilar 1. Target and Function Tilvestamab (BGB149) is a humanized monoclonal antibody that targets the AXL Read More...